Aptamers, single-stranded oligonucleotides capable of binding to specific targets, are composed of only four similar nucleobases, limiting their therapeutic potential. Now, alenomers—DNA-barcoded, chemically diverse aptamer-like molecules that integrate amino acids, lipids and sugars at precise sites—have been developed. This modular platform enables the rapid discovery of high-affinity, stable aptamers.
- Daniel Saliba
- Eiman A. Osman
- Hanadi F. Sleiman